CareDx, Inc. (CDNA) vs Personalis, Inc. (PSNL)

CareDx, Inc. and Personalis, Inc. are both Diagnostics & Research companies. CareDx, Inc. is the larger, with a market value of $4.0B against $1.7B — 2.4× the size. Personalis, Inc. has negative trailing earnings, so its P/E is not meaningful; CareDx, Inc. trades at 30.9×. CareDx, Inc. grew revenue faster over the last twelve months: 38.9% against 16.9%. CareDx, Inc. has the higher net margin (25.9% vs −147.7%) and the higher return on invested capital (33.6% vs −358.4%). Across the 17 metrics below, CareDx, Inc. leads on 13 and Personalis, Inc. on 4.

Valuation

Metric CDNA PSNL Diagnostics & Research median
P/E 30.91 n/m 34.52
P/S 8.06 20.71 4.24
P/B 8.58 7.86 3.42
Price to free cash flow 68.93 n/m 33.51
EV/EBITDA 26.62 n/m 23.44
EV/Sales 7.57 18.57 5.18
Earnings yield 3.24% (7.50%) (1.50%)
Free cash flow yield 1.45% (6.35%) 0.00%

Profitability

Metric CDNA PSNL Diagnostics & Research median
Gross margin 70.97% 16.71% 48.32%
Operating margin 23.42% (156.66%) (5.68%)
Net margin 25.86% (147.74%) (4.10%)
Free cash flow margin 12.01% (120.79%) 0.00%
Return on equity 33.04% (62.14%) 0.00%
Return on assets 23.96% (44.66%) (6.05%)
Return on invested capital 33.56% (358.37%) 0.00%

Growth

Metric CDNA PSNL Diagnostics & Research median
Revenue growth (TTM) 38.94% 16.88% 8.99%
EPS growth (last fiscal year) (143.01%) 33.58% 20.36%
Revenue growth, 5-year CAGR 14.59% (2.40%) 7.30%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CDNA PSNL Diagnostics & Research median
Debt to equity 0.00 0.00 0.01
Current ratio 2.31 4.53 2.27
Net debt to EBITDA 19.49 2.93 0.68

Dividend

Metric CDNA PSNL Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric CDNA PSNL Diagnostics & Research median
Market cap 4.01b 1.69b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack